尼托胺缓解:在甲福明化片中,NDMA杂质的形成及其抑制
Diaa Shakleya1, Alaadin Alayoubi1, Dustin Brown1
1Food and Drug Administration, Center for Drug Evaluation and Research, Office of Pharmaceutical Quality, Office of Pharmaceutical Quality Research, 10903 New Hampshire Avenue, Silver Spring, MD 20993, USA.
基本的pH值和抗氧化剂有效地减轻了在甲福林化片中的N-尼二甲基胺 (NDMA) 形成. 较高的抗氧化剂度 (0.5-1%) 实现了完全的NDMA抑制,显示了药物产品安全性的前景.
科学领域:
- 制药化学 制药化学 的相关文章
- 药物配方科学 药物配方科学
背景情况:
- 药物产品中酸胺的形成是一个重大的安全问题.
- 现有的缓解策略包括pH调节剂和抗氧化剂,但需要对各种药物模型进行进一步调查.
研究的目的:
- 评估各种抗氧化剂和pH调节剂在缓解N-尼二甲基胺 (NDMA) 形成方面的有效性.
- 评估这些策略在甲福林化片配方中.
主要方法:
- 甲福明化片使用湿颗粒与酸盐尖端制备.
- 配方中含有抗氧化剂 (酸,咖啡酸,酸) 和pH值修饰剂 (盐酸,碳酸).
- 药片经过六个月的稳定性测试 (湿度,温度,时间).
主要成果:
- 基本pH值显著增强了NDMA抑制.
- 抗氧化剂显示出有效性,0.1%的度提供了显著的抑制.
- 所有测试的抗氧化剂的0.5%和1%度导致了完全的NDMA缓解.
结论:
- 基本pH值是减少甲福林化片中NDMA形成的一个关键因素.
- 抗氧化剂,特别是高度的抗氧化剂,可以有效地防止NDMA的产生.
- 这些发现支持使用基本pH值和抗氧化剂作为在制药配方中减轻尼托拉胺的可行策略.
更多相关视频
09:24Application and Methodology of the Non-destructive 19F Time-domain NMR Technique to Measure the Content in Fluorine-containing Drug Products
Published on: August 22, 2017
06:07Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
Published on: August 5, 2022
相关概念视频
2° Amines to N-Nitrosamines: Reaction with NaNO2
Preparation of Amines: Reductive Amination of Aldehydes and Ketones
Preparation of Amines: Reduction of Oximes and Nitro Compounds
Though catalytic hydrogenation can reduce nitrobenzenes, the reduction is nonselective in the presence of other functional groups. For instance, if nitrobenzene contains an aldehyde group,...
Preparation of 1° Amines: Gabriel Synthesis
Strong bases like NaOH or KOH deprotonate the phthalimide to form the corresponding anion, which acts as a nucleophile. Further, the anion attacks an...
Drugs Affecting Neurotransmitter Synthesis
Preparation of 1° Amines: Hofmann and Curtius Rearrangement Overview
